- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06160726
MRI-based Artificial Intelligence Software (NNS-SOT) for Onset Time Estimation in Lesion With Acute Ischemic Stroke
November 29, 2023 updated by: Nunaps Inc
Evaluating the Validation of MRI-based Artificial Intelligence Software (NNS-SOT) for Onset Time Estimation in Lesion With Acute Ischemic Stroke : a Single-center, Single-arm, Single-blind (Evaluator), Retrospective Pivotal Trial
This study evaluates the efficacy of investigational device named Stroke Onset Time Artificial Intelligence(AI) (Model name:NNS-SOT).
Using the investigational device, analyze the image and the onset time of occurrence of acute ischemic stroke lesion on the brain image (4.5 hours or more from the onset of symptoms) and evaluate the efficacy of correctly estimating the onset time.
Study Overview
Status
Completed
Conditions
Detailed Description
This clinical trial software medical device (Model name: NNS-SOT) is developed based on artificial intelligence algorithms.
Through clinical validation, it will be easier to determine whether the golden hour (4.5 hours) has elapsed at the time of cerebral infarction in the medical field. It can be used for estimation of the onset time of occurrence in acute ischemic stroke.
Study Type
Observational
Enrollment (Actual)
474
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Asan Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Cerebral infarction disease Brain imaging data taken from 474 subjects who visited clinical trial institution (From 2017 to March 27, 2023)
Description
Inclusion Criteria:
- Brain imaging in patients with acute ischemic stroke aged 20 years and older
- Brain imaging of ischemic stroke manifestation lesion confirmed by medical staff in brain MR image
- Brain imaging taken within 24 hours of ischemic stroke symptoms
- Brain imaging including Magnetic Resonance(MR) images (DWI and FLAIR)
- Patients with clearly recorded onset time of acute ischemic stroke symptoms
Exclusion Criteria:
- Brain imaging used in NNS-SOT development process
- Brain imaging with noise (Artifact)
- Brain images damaged in data
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity and specificity
Time Frame: October - November 2023
|
Evaluation of sensitivity and specificity of clinical performance (estimation of 4.5 hours or more after cerebral infarction) performed with clinical trial medical device
|
October - November 2023
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Area Under the Curve(AUC), which is the lower area of the Receiver Operating Characteristics(ROC) curve
Time Frame: October - November 2023
|
Lower limit of 95% confidence interval is 80% or more
|
October - November 2023
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bum Joon Kim, MD, PhD, Asan Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 24, 2023
Primary Completion (Actual)
November 7, 2023
Study Completion (Actual)
November 7, 2023
Study Registration Dates
First Submitted
November 29, 2023
First Submitted That Met QC Criteria
November 29, 2023
First Posted (Estimated)
December 7, 2023
Study Record Updates
Last Update Posted (Estimated)
December 7, 2023
Last Update Submitted That Met QC Criteria
November 29, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NNS-SOT-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.